Psivida recently announced an updated agreement with pharmaceutical giant Pfizer. The research and development agreement will focus on the development of a long-term, controlled-release implant to deliver latanoprost (traditionally formulated as...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)